James L Leach1,2, James Roebker1,2, Austin Schafer3, Joshua Baugh3,4, Brooklyn Chaney3, Christine Fuller5, Maryam Fouladi3, Adam Lane3, Renee Doughman3, Rachid Drissi3,6, Mariko DeWire-Schottmiller3, David S Ziegler7, Jane E Minturn8, Jordan R Hansford9, Stacie S Wang9, Michelle Monje-Deisseroth10, Paul G Fisher10, Nicholas G Gottardo11, Hetal Dholaria11, Roger Packer12, Katherine Warren13, Sarah E S Leary14, Stewart Goldman15, Ute Bartels16, Cynthia Hawkins17, Blaise V Jones1. 1. Department of Radiology and Medical Imaging, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 2. Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio. 3. Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 4. Department of Neuro-oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. 5. Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 6. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. 7. Kids Cancer Centre, Sydney Children's Hospital, Sydney, AU. 8. Division of Oncology, Children's Hospital of Philadelphia, Pennsylvania. 9. Children's Cancer Centre, Royal Children's Hospital; Murdoch Children's Research Institute; University of Melbourne, Melbourne, Australia. 10. Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California. 11. Department of Oncology, Perth Children's Hospital, Perth, AU. 12. Division of Oncology, Children's National Medical Center, Washington, DC. 13. Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Harvard Cancer Center, Boston Massachusetts. 14. Cancer and Blood Disorders Center, Seattle Children's, Seattle, Washington. 15. Division of Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 16. Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, CA. 17. Division of Pathology, The Hospital for Sick Children, Toronto, CA.
Abstract
BACKGROUND: This study describes imaging features of diffuse intrinsic pontine glioma (DIPG) and correlates with overall survival (OS) and histone mutation status in the International DIPG Registry (IDIPGR). METHODS: Four hundred cases submitted to the IDIPGR with a local diagnosis of DIPG and baseline MRI were evaluated by consensus review of 2 neuroradiologists; 43 cases were excluded (inadequate imaging or alternative diagnoses). Agreement between reviewers, association with histone status, and univariable and multivariable analyses relative to OS were assessed. RESULTS: On univariable analysis imaging features significantly associated with worse OS included: extrapontine extension, larger size, enhancement, necrosis, diffusion restriction, and distant disease. On central review, 9.5% of patients were considered not to have DIPG. There was moderate mean agreement of MRI features between reviewers. On multivariable analysis, chemotherapy, age, and distant disease were predictors of OS. There was no difference in OS between wild-type and H3 mutated cases. The only imaging feature associated with histone status was the presence of ill-defined signal infiltrating pontine fibers. CONCLUSIONS: Baseline imaging features are assessed in the IDIPGR. There was a 9.5% discordance in DIPG diagnosis between local and central review, demonstrating need for central imaging confirmation for prospective trials. Although several imaging features were significantly associated with OS (univariable), only age and distant disease were significant on multivariable analyses. There was limited association of imaging features with histone mutation status, although numbers are small and evaluation exploratory.
BACKGROUND: This study describes imaging features of diffuse intrinsic pontine glioma (DIPG) and correlates with overall survival (OS) and histone mutation status in the International DIPG Registry (IDIPGR). METHODS: Four hundred cases submitted to the IDIPGR with a local diagnosis of DIPG and baseline MRI were evaluated by consensus review of 2 neuroradiologists; 43 cases were excluded (inadequate imaging or alternative diagnoses). Agreement between reviewers, association with histone status, and univariable and multivariable analyses relative to OS were assessed. RESULTS: On univariable analysis imaging features significantly associated with worse OS included: extrapontine extension, larger size, enhancement, necrosis, diffusion restriction, and distant disease. On central review, 9.5% of patients were considered not to have DIPG. There was moderate mean agreement of MRI features between reviewers. On multivariable analysis, chemotherapy, age, and distant disease were predictors of OS. There was no difference in OS between wild-type and H3 mutated cases. The only imaging feature associated with histone status was the presence of ill-defined signal infiltrating pontine fibers. CONCLUSIONS: Baseline imaging features are assessed in the IDIPGR. There was a 9.5% discordance in DIPG diagnosis between local and central review, demonstrating need for central imaging confirmation for prospective trials. Although several imaging features were significantly associated with OS (univariable), only age and distant disease were significant on multivariable analyses. There was limited association of imaging features with histone mutation status, although numbers are small and evaluation exploratory.
Authors: Tina Young Poussaint; Mehmet Kocak; Sridhar Vajapeyam; Roger I Packer; Richard L Robertson; Russell Geyer; Daphne Haas-Kogan; Ian F Pollack; Gilbert Vezina; Robert Zimmerman; Soonmee Cha; Zoltan Patay; James M Boyett; Larry E Kun Journal: Neuro Oncol Date: 2011-02-04 Impact factor: 12.300
Authors: Alexandra Sufit; Andrew M Donson; Diane K Birks; Jeffrey A Knipstein; Laura Z Fenton; Paul Jedlicka; Todd C Hankinson; Michael H Handler; Nicholas K Foreman Journal: J Neurosurg Pediatr Date: 2012-06-29 Impact factor: 2.375
Authors: L Makepeace; M Scoggins; B Mitrea; Y Li; A Edwards; C L Tinkle; S Hwang; A Gajjar; Z Patay Journal: AJNR Am J Neuroradiol Date: 2020-01-23 Impact factor: 3.825
Authors: Ashley E Conway; Wilburn E Reddick; Yimei Li; Ying Yuan; John O Glass; Justin N Baker; Larry E Kun; Alberto Broniscer; Zoltan Patay Journal: Neuroradiology Date: 2014-03-14 Impact factor: 2.804
Authors: Sophie E M Veldhuijzen van Zanten; Joshua Baugh; Brooklyn Chaney; Dennis De Jongh; Esther Sanchez Aliaga; Frederik Barkhof; Johan Noltes; Ruben De Wolf; Jet Van Dijk; Antonio Cannarozzo; Carin M Damen-Korbijn; Jan A Lieverst; Niclas Colditz; Marion Hoffmann; Monika Warmuth-Metz; Brigitte Bison; David T W Jones; Dominik Sturm; Gerrit H Gielen; Chris Jones; Esther Hulleman; Raphael Calmon; David Castel; Pascale Varlet; Géraldine Giraud; Irene Slavc; Stefaan Van Gool; Sandra Jacobs; Filip Jadrijevic-Cvrlje; David Sumerauer; Karsten Nysom; Virve Pentikainen; Sanna-Maria Kivivuori; Pierre Leblond; Natasha Entz-Werle; Andre O von Bueren; Antonis Kattamis; Darren R Hargrave; Péter Hauser; Miklos Garami; Halldora K Thorarinsdottir; Jane Pears; Lorenza Gandola; Giedre Rutkauskiene; Geert O Janssens; Ingrid K Torsvik; Marta Perek-Polnik; Maria J Gil-da-Costa; Olga Zheludkova; Liudmila Shats; Ladislav Deak; Lidija Kitanovski; Ofelia Cruz; Andres Morales La Madrid; Stefan Holm; Nicolas Gerber; Rejin Kebudi; Richard Grundy; Enrique Lopez-Aguilar; Marta Zapata-Tarres; John Emmerik; Tim Hayden; Simon Bailey; Veronica Biassoni; Maura Massimino; Jacques Grill; William P Vandertop; Gertjan J L Kaspers; Maryam Fouladi; Christof M Kramm; Dannis G van Vuurden Journal: J Neurooncol Date: 2017-01-21 Impact factor: 4.130
Authors: Sophie E M Veldhuijzen van Zanten; Adam Lane; Martijn W Heymans; Joshua Baugh; Brooklyn Chaney; Lindsey M Hoffman; Renee Doughman; Marc H A Jansen; Esther Sanchez; William P Vandertop; Gertjan J L Kaspers; Dannis G van Vuurden; Maryam Fouladi; Blaise V Jones; James Leach Journal: J Neurooncol Date: 2017-05-30 Impact factor: 4.130
Authors: Alexander G Yearley; Julian Bryan Iorgulescu; Ennio Antonio Chiocca; Pier Paolo Peruzzi; Timothy R Smith; David A Reardon; Michael A Mooney Journal: Neurooncol Adv Date: 2022-06-24
Authors: Margot A Lazow; Martijn T Nievelstein; Adam Lane; Pratiti Bandopadhayhay; Mariko DeWire-Schottmiller; Maryam Fouladi; John W Glod; Robert J Greiner; Lindsey M Hoffman; Trent R Hummel; Lindsay Kilburn; Sarah Leary; Jane E Minturn; Roger Packer; David S Ziegler; Brooklyn Chaney; Katie Black; Peter de Blank; James L Leach Journal: Neuro Oncol Date: 2022-09-01 Impact factor: 13.029
Authors: Margot A Lazow; Christine Fuller; Mariko DeWire; Adam Lane; Pratiti Bandopadhayay; Ute Bartels; Eric Bouffet; Sylvia Cheng; Kenneth J Cohen; Tabitha M Cooney; Scott L Coven; Hetal Dholaria; Blanca Diez; Kathleen Dorris; Moatasem El-Ayadi; Ayman El-Sheikh; Paul G Fisher; Adriana Fonseca; Mercedes Garcia Lombardi; Robert J Greiner; Stewart Goldman; Nicholas Gottardo; Sridharan Gururangan; Jordan R Hansford; Tim Hassall; Cynthia Hawkins; Lindsay Kilburn; Carl Koschmann; Sarah E Leary; Jie Ma; Jane E Minturn; Michelle Monje-Deisseroth; Roger Packer; Yvan Samson; Eric S Sandler; Gustavo Sevlever; Christopher L Tinkle; Karen Tsui; Lars M Wagner; Mohamed Zaghloul; David S Ziegler; Brooklyn Chaney; Katie Black; Anthony Asher; Rachid Drissi; Maryam Fouladi; Blaise V Jones; James L Leach Journal: Neuro Oncol Date: 2022-05-04 Impact factor: 13.029
Authors: Nirav Patil; Michael E Kelly; Debra Nana Yeboa; Robin A Buerki; Gino Cioffi; Sweta Balaji; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2021-06-01 Impact factor: 12.300
Authors: Craig Erker; Adam Lane; Brooklyn Chaney; Sarah Leary; Jane E Minturn; Ute Bartels; Roger J Packer; Kathleen Dorris; Nicholas G Gottardo; Katherine E Warren; Alberto Broniscer; Mark W Kieran; Xiaoting Zhu; Peter White; Phillip J Dexheimer; Katie Black; Anthony Asher; Mariko DeWire; Jordan R Hansford; Sridharan Gururangan; Javad Nazarian; David S Ziegler; Eric Sandler; Allison Bartlett; Stewart Goldman; Chie-Schin Shih; Tim Hassall; Hetal Dholaria; Pratiti Bandopadhayay; Yvan Samson; Michelle Monje; Paul G Fisher; Andrew Dodgshun; Sarah Parkin; Murali Chintagumpala; Karen Tsui; David Gass; Valerie Larouche; Emmett Broxson; Mercedes Garcia Lombardi; Stacie Shiqi Wang; Jie Ma; Cynthia Hawkins; Dima Hamideh; Lars Wagner; Carl Koschmann; Christine Fuller; Rachid Drissi; Blaise V Jones; James Leach; Maryam Fouladi Journal: Neuro Oncol Date: 2022-01-05 Impact factor: 13.029